Welcome to our dedicated page for Orasure Tech news (Ticker: OSUR), a resource for investors and traders seeking the latest updates and insights on Orasure Tech stock.
OraSure Technologies Inc (OSUR) is a leader in non-invasive diagnostic solutions and molecular testing systems for global healthcare markets. This comprehensive news hub provides investors and healthcare professionals with essential updates on corporate developments, regulatory milestones, and product innovations.
Access timely updates including earnings reports, FDA clearances, clinical trial results, and strategic partnerships. Our curated collection features press releases covering oral fluid diagnostics advancements, molecular testing solutions, and cryosurgical product developments – all critical for assessing the company's market position.
Key content categories include financial performance disclosures, manufacturing expansion announcements, research collaborations, and public health initiatives. The archive serves as a vital resource for tracking OSUR's contributions to HIV testing, substance abuse screening, and genetic material stabilization technologies.
Bookmark this page for streamlined monitoring of OraSure's operational updates and industry leadership in medical device innovation. Check regularly for authoritative information supporting informed analysis of this diagnostic technology pioneer.
OraSure Technologies, Inc. reported Q1 '24 revenue of $54.1 million with a GAAP EPS of $(0.05) and Non-GAAP EPS of $0.04. Restructuring initiatives are expected to yield $15 million in annual expense reductions. Recent actions aim to streamline the business and achieve cash flow breakeven by end of 2024. The company is investing in innovation and partnerships to drive long-term growth.
FAQ
What is the current stock price of Orasure Tech (OSUR)?
What is the market cap of Orasure Tech (OSUR)?
